澳门金沙www7727scom

About Us

Executive team

Home>About Us>Executive team
王春城总_conew2.jpg

Mr. WANG Chuncheng

Mr. WANG Chuncheng, serves as an executive vice president of China Resources (Holdings) Company Limited (“CR Holdings”), concurrently serves as the chairman of the Board, chief executive officer of China Resources Pharmaceutical Group Limited and also serves as the chairman of China Resources Sanjiu Medical & Pharmaceutical Company Limited (“CR Sanjiu”), a company listed on Shenzhen Stock Exchange (stock code: 000999), the chairman of Dong-E-E-Jiao Company Limited ("Dong-E-E-Jiao”), a company listed on Shenzhen Stock Exchange (stock code: 000423), the chairman of China Resources Jiangzhong Pharmaceutical Group Co., Ltd. (澳门金沙www7727scom江中制药集团有限责任公司). Mr. WANG has over 20 years of experience in corporate management, Mr. WANG holds a bachelor’s degree in economics from Jilin University of Finance and Economics. He joined CR Holdings in 1997.
吴峻.jpg

Mr. WU Jun

Mr. WU Jun, the senior vice president of the Company. Currently, Mr. WU also serves as a director of CR Sanjiu, a director of Dong-E-E-Jiao, a supervisor of CR Double-Crane. Mr. WU has been a director and the general manager of China Resources Machinery and Minmetals (Holdings) Co., Ltd. (澳门金沙www7727scom机械五矿(集团)有限公司), a deputy general manager in the enterprise development department of CR Holdings, a director and deputy general manager of CR Investment & Development Company Limited (澳门金沙www7727scom投资开发有限公司), a deputy general manager in the internal audit department of CR Holdings and a vice president of the Company. Mr. WU obtained the qualification of senior engineer in China and he obtained a master’s degree in mechanical engineering from Tianjin University and an MBA degree from University of San Francisco in San Francisco, the United States of America. 
陈宏.jpg

Mr. CHEN Hong

Mr. CHEN Hong, the senior vice president of the Company. Mr. CHEN has been a deputy factory manager of Beijing Second Pharmaceutical Factory (北京第二制药厂), currently known as China Resources Saike Pharmaceutical Co., Ltd. (澳门金沙www7727scom赛科药业有限责任公司), the chairman of Beijing Saike Pharmaceutical Co., Ltd. (北京赛科药业有限责任公司), currently known as China Resources Saike Pharmaceutical Co., Ltd. (澳门金沙www7727scom赛科药业有限责任公司), a vice general manager of Beijing Pharmaceutical Co., Ltd. (北京医药集团有限责任公司) and the vice president of the Company. Mr. CHEN was awarded prizes like “Capital May Day Labor Medal” (首都五一劳动奖章), “Model Workers in Beijing” (北京市劳动模范) and “National May Day Labor Medal” (全国五一劳动奖章). Mr. CHEN obtained the qualification of assistant engineer in China and he attended undergraduate class majoring in economic management in the Party School of Beijing Municipal Committee of the CPC (中共北京市市委党校).
殷惠军.jpg

Mr. YIN Huijun

Mr. YIN Huijun, the senior vice president of the Company. Currently, Mr. YIN also serves as the chairman of China Pharmaceutical R&D Center Co., Ltd. (中国医药研究发展中心有限公司), a deputy secretary-general of Medical and Health sector of All-China Youth Federation (中华全国青联医药卫生界别), a council member of China Association of Youth Science and Technology (中国青年科技协会), a standing member of Special Committee on Cardiovascular under Doctor Society of Integrative Medicine (中西医结合医师协会心血管专业委员会), a Ph.D. tutor of China Academy of Chinese Medical Sciences, and a graduate student tutor of Gansu University of Chinese Medicine. Mr. YIN has served as the cardiovascular laboratory officer of Xiyuan Hospital under China Academy of Chinese Medical Sciences (the former China Academy of Traditional Chinese Medicine), a standing director of Specialty Committee of Cardiovascular Diseases of World Federation of Chinese Medicine Societies, a vice president of Affiliated Hospital of Gansu University of Chinese Medicine and the chief of international cooperation department of China Academy of Chinese Medical Sciences. Mr. YIN was awarded the “Star of Science and Technology” by TCM Society and the Second Class Prize for Progress of National Science and Technology (国家科技进步二等奖). Mr. YIN obtained the qualification of researcher issued by China Academy of Chinese Medical Sciences. Mr. YIN obtained a doctor’s degree in Chinese internal medicine from Heilongjiang College of Chinese Medicine (currently known as Heilongjiang University of Chinese Medicine (黑龙江中医药大学)) in Harbin, the PRC. Mr. YIN conducted his postdoctoral research in Institute of Genetics and Developmental Biology, Chinese Academy of Sciences.

Mdm. WENG Jingwen

Mdm. WENG Jingwen, was appointed as an executive Director, chief financial officer and vice president of the Company in July 2019, has 12 years of experience in financial management and auditing and 8 years of experience in strategic development and business analysis. Mdm. WENG also serves as a director of CR Sanjiu and China Resources Double-Crane Pharmaceutical Company Limited(澳门金沙www7727scom双鹤药业股份有限公司)(the shares of which are listed on the Shanghai Stock Exchange, Stock Code: 600062). Mdm. WENG joined China Resources Group in 2004 and served as a general manager of internal audit department and strategic controller of China Resources Gas Group Limited (the shares of which are listed on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), Stock Code: 1193), deputy strategic development controller of China Resources (Holdings) Company Limited (with a focus in pharmaceutical and healthcare areas). Mdm. WENG was previously engaged in financial management and auditing job in the International Business Machines Corporation and PricewaterhouseCoopers before joining China Resources Group. Mdm. WENG obtained a bachelor’s degree in economics from Zhejiang University and an MBA degree from the Hong Kong University of Science and Technology. 

Mr. MENG Qingsheng

Mr. MENG Qingsheng, the vice president of the Company. Mr. MENG has engaged in the Information Technology (IT) consultancy and management business for over 20 years. Mr. MENG has extensive experience in areas like corporate IT strategic planning, system structural design, project management and the training of professional personnel. Mr. MENG successively held positions in SSA China Co., Ltd., Platinum China Co., Ltd. and Oracle China Co., Ltd.. Mr. MENG has also acted as a deputy director of the Information Management Department of CR Holdings.
唐娜.jpg

Ms. TANG Na

Ms. TANG Na, the chief legal advisor of the Company. Ms. TANG served as a partner of Concord & Partners and a director of legal affairs of CR Pharmaceutical Commercial. Ms. TANG obtained the qualification of PRC lawyer and the corporate counsel qualification. Ms. TANG obtained a bachelor of law degree from China University of Political Science and Law in Beijing, the PRC and attended postgraduate courses majoring in urban economics in the School of Economics at Renmin University of China in Beijing, the PRC.

Mr. JIN Song

Mr. JIN Song, the assistant president of the Company. Mr. JIN served as a division-level consultant at the State Food and Drug Administration of the PRC (currently known as the China Food and Drug Administration of the PRC). Mr. JIN obtained a master’s degree in international cooperation policy from Ritsumeikan University in Kyoto, Japan.

Mr. ZHAO Bingxiang

Mr. ZHAO Bingxiang, the assistant president of the Company and the chairman of China Resources Zizhu Pharmaceutical Co., Ltd. (澳门金沙www7727scom紫竹药业有限公司). Mr. ZHAO had served as a regional sales manager and a marketing officer of San-jiu Pharmaceutical Trade Co., Ltd. (三九医药贸易有限公司), a deputy general manager of San-jiu Tongda Pharmaceutical Co., Ltd. (三九同达药业有限公司), a senior researcher of the R&D center of CR Sanjiu and a general manager of China Resources Sanjiu (Ya’an) Pharmaceutical Co., Ltd. (澳门金沙www7727scom三九(雅安)药业有限公司). Mr. ZHAO has been named as an excellent entrepreneur and an outstanding entrepreneur in Sichuan province, he has received the State Scientific and Technological Progress Award — second-class and the Sichuan Scientific and Technological Progress Award — first-class. Mr. ZHAO is a professor-level senior engineer and he holds a master’s degree in Pharmaceutics awarded by Peking University in Beijing, the PRC.

Mr. TAO Ran

Mr. TAO Ran, the assistant president of the Company. Mr. TAO has been a deputy chief of Import Division I of China Resources National Corporation (currently known as China Resources Company Limited), a senior manager of Investment Division, a general manager of Strategy Division and a deputy general manager of China Resources Textiles (Holdings) Co., Ltd. and a senior director of Strategic Development Division, a general manager of Strategic Development Division of the Company. Mr. TAO holds a bachelor’s degree in engineering awarded by Shanghai Jiao Tong University in Shanghai and a master’s degree in economics awarded by School of Economics and Management of Beihang University.

Mr. WU Jianjun

Mr. WU Jianjun, the assistant president of the Company. Mr. WU had been a vice director of Workshop, a vice head of Sales Division and a vice head of Foreign Trade Division of Beijing Hua’er Company Limited (北京化二股份有限公司), an assistant researcher of Enterprise Reform Office of Beijing Municipal Commission of Economy and Information Technology (北京市经委企业改革处), a vice head of Enterprise Reform Office of the State-owned Assets Supervision and Administration Commission of Beijing, an assistant to the general manager of Beijing Pharmaceutical Co., Ltd. (北京医药集团有限责任公司), a director of China Resources Pharmaceutical (Beijing) Industrial Development Co., Ltd. (澳门金沙www7727scom(北京)产业发展有限公司), a senior director of Production and Manufacturing Division and a general manager of the Office of the Company. Mr. WU holds an executive master’s degree in Business Administration awarded by Tsinghua University in Beijing, the PRC.